JP2014221801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014221801A5 JP2014221801A5 JP2014142904A JP2014142904A JP2014221801A5 JP 2014221801 A5 JP2014221801 A5 JP 2014221801A5 JP 2014142904 A JP2014142904 A JP 2014142904A JP 2014142904 A JP2014142904 A JP 2014142904A JP 2014221801 A5 JP2014221801 A5 JP 2014221801A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- helix
- enhanced
- modified
- helix polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 55
- 229920001184 polypeptide Polymers 0.000 claims 54
- 102000004196 processed proteins & peptides Human genes 0.000 claims 54
- 238000000034 method Methods 0.000 claims 41
- 150000001413 amino acids Chemical class 0.000 claims 16
- 239000003431 cross linking reagent Substances 0.000 claims 13
- 210000004027 cell Anatomy 0.000 claims 5
- 210000000170 cell membrane Anatomy 0.000 claims 5
- 230000002378 acidificating effect Effects 0.000 claims 4
- 230000002209 hydrophobic effect Effects 0.000 claims 4
- 102000004506 Blood Proteins Human genes 0.000 claims 3
- 108010017384 Blood Proteins Proteins 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 230000001419 dependent effect Effects 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 230000003834 intracellular effect Effects 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 238000003556 assay Methods 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000003463 hyperproliferative effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 101100455978 Arabidopsis thaliana MAM1 gene Proteins 0.000 claims 1
- 102000051485 Bcl-2 family Human genes 0.000 claims 1
- 108700038897 Bcl-2 family Proteins 0.000 claims 1
- 102100031633 Chorionic somatomammotropin hormone-like 1 Human genes 0.000 claims 1
- 108010016626 Dipeptides Proteins 0.000 claims 1
- 101000940558 Homo sapiens Chorionic somatomammotropin hormone-like 1 Proteins 0.000 claims 1
- 102000005650 Notch Receptors Human genes 0.000 claims 1
- 108010070047 Notch Receptors Proteins 0.000 claims 1
- 230000001594 aberrant effect Effects 0.000 claims 1
- 239000007801 affinity label Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 239000012466 permeate Substances 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9906308P | 2008-09-22 | 2008-09-22 | |
| US61/099,063 | 2008-09-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011528084A Division JP5711128B2 (ja) | 2008-09-22 | 2009-09-22 | ペプチド模倣大環状分子 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016159624A Division JP2016190882A (ja) | 2008-09-22 | 2016-08-16 | ペプチド模倣大環状分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014221801A JP2014221801A (ja) | 2014-11-27 |
| JP2014221801A5 true JP2014221801A5 (enExample) | 2015-09-10 |
| JP6067626B2 JP6067626B2 (ja) | 2017-01-25 |
Family
ID=41611441
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011528084A Expired - Fee Related JP5711128B2 (ja) | 2008-09-22 | 2009-09-22 | ペプチド模倣大環状分子 |
| JP2014142904A Expired - Fee Related JP6067626B2 (ja) | 2008-09-22 | 2014-07-11 | ペプチド模倣大環状分子 |
| JP2016159624A Pending JP2016190882A (ja) | 2008-09-22 | 2016-08-16 | ペプチド模倣大環状分子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011528084A Expired - Fee Related JP5711128B2 (ja) | 2008-09-22 | 2009-09-22 | ペプチド模倣大環状分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016159624A Pending JP2016190882A (ja) | 2008-09-22 | 2016-08-16 | ペプチド模倣大環状分子 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US8524653B2 (enExample) |
| EP (1) | EP2342222B1 (enExample) |
| JP (3) | JP5711128B2 (enExample) |
| CN (1) | CN102482336B (enExample) |
| AU (1) | AU2009294877C1 (enExample) |
| BR (1) | BRPI0918948A2 (enExample) |
| CA (1) | CA2737922A1 (enExample) |
| ES (1) | ES2666458T3 (enExample) |
| IL (1) | IL211836A0 (enExample) |
| WO (1) | WO2010034034A1 (enExample) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| CN103467588B (zh) | 2003-11-05 | 2016-12-28 | 达纳-法伯癌症研究所股份有限公司 | 稳定的α螺旋肽及其用途 |
| WO2005118620A2 (en) | 2004-05-27 | 2005-12-15 | New York University | Methods for preparing internally constraied peptides and peptidomimetics |
| EP3170835A1 (en) * | 2006-12-14 | 2017-05-24 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| US7981998B2 (en) * | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| US8889632B2 (en) | 2007-01-31 | 2014-11-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| EP2564862B1 (en) * | 2007-02-23 | 2017-08-02 | Aileron Therapeutics, Inc. | Substituted amino acids for preparing triazole linked macrocyclic peptides |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| WO2009110952A2 (en) * | 2007-12-31 | 2009-09-11 | New York University | Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| CN104474529A (zh) | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
| US20110144303A1 (en) * | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
| WO2010011313A2 (en) | 2008-07-23 | 2010-01-28 | President And Fellows Of Harvard College | Ligation of stapled polypeptides |
| CN102482336B (zh) | 2008-09-22 | 2015-05-06 | 爱勒让治疗公司 | 拟肽大环化合物 |
| WO2010034032A2 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutic, Inc. | Methods for preparing purified polypeptide compositions |
| JP2012509902A (ja) * | 2008-11-24 | 2012-04-26 | エルロン・セラピューティクス・インコーポレイテッド | 改善された特性を有するペプチド模倣大環状分子 |
| WO2010083347A2 (en) | 2009-01-14 | 2010-07-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2011008260A2 (en) | 2009-07-13 | 2011-01-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| CA2774973A1 (en) | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CA2777700A1 (en) * | 2009-10-14 | 2011-04-21 | Aileron Therapeutics, Inc. | Improved peptidomimetic macrocycles |
| RU2016111360A (ru) | 2010-08-13 | 2018-11-27 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
| US8957026B2 (en) | 2010-09-22 | 2015-02-17 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| WO2012051405A1 (en) | 2010-10-13 | 2012-04-19 | Bristol-Myers Squibb Company | Methods for preparing macrocycles and macrocycle stabilized peptides |
| AU2011325910B2 (en) | 2010-11-12 | 2016-03-24 | Dana Farber Cancer Institute, Inc. | Cancer therapies and diagnostics |
| EP2651964B1 (en) | 2010-12-15 | 2018-02-28 | The Research Foundation of State University of New York | Cross-linked peptides and proteins, methods of making same, and uses thereof |
| EP2721061A4 (en) * | 2011-06-17 | 2014-11-05 | Harvard College | VARIANT STABILIZED MAML-PEPTIDES AND USES THEREOF |
| WO2012174423A1 (en) | 2011-06-17 | 2012-12-20 | President And Fellows Of Harvard College | Stabilized polypeptides as regulators of rab gtpase function |
| WO2013033645A1 (en) * | 2011-08-31 | 2013-03-07 | New York University | Thioether-,ether-, and alkylamine-linked hydrogen bond surrogate pertidomimentics |
| CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| RU2017145921A (ru) | 2012-02-15 | 2019-02-21 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
| EP2920197B1 (en) | 2012-09-26 | 2021-03-17 | President and Fellows of Harvard College | Proline-locked stapled peptides and uses thereof |
| CN104812384B (zh) | 2012-11-01 | 2020-09-18 | 爱勒让治疗公司 | 二取代的氨基酸及其制备和使用方法 |
| US20140205681A1 (en) * | 2013-01-19 | 2014-07-24 | New York University | HYDROGEN-BOND SURROGATE PEPTIDES AND PEPTIDOMIMETICS FOR p53 REACTIVATION |
| JP6568515B2 (ja) | 2013-03-13 | 2019-08-28 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステープルドおよびステッチドポリペプチドならびにその使用 |
| MX2015017274A (es) | 2013-06-14 | 2016-08-04 | Harvard College | Moduladores del receptor del polipéptido insulina estabilizados. |
| ES2927607T3 (es) | 2013-09-13 | 2022-11-08 | Scripps Research Inst | Agentes terapéuticos modificados y composiciones de los mismos |
| US10039809B2 (en) | 2013-12-18 | 2018-08-07 | The California Institute For Biomedical Research | Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof |
| JP6759109B2 (ja) | 2014-05-21 | 2020-09-23 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Ｒａｓ抑制性ペプチドおよびその使用 |
| JP2017533889A (ja) | 2014-09-24 | 2017-11-16 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその使用 |
| MX389354B (es) | 2014-09-24 | 2025-03-20 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y formulaciones de los mismos. |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| KR102665898B1 (ko) * | 2015-06-25 | 2024-05-14 | 에이지씨 가부시키가이샤 | 발수제 조성물, 발수제 조성물의 제조 방법 및 물품 |
| US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| US10023613B2 (en) | 2015-09-10 | 2018-07-17 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles as modulators of MCL-1 |
| CN108541221B (zh) * | 2015-12-15 | 2023-02-28 | 格礼卡姆股份公司 | Hmo的混合物 |
| JP2019520304A (ja) * | 2016-03-21 | 2019-07-18 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子に関するコンパニオン診断ツール |
| US12059413B2 (en) | 2016-11-02 | 2024-08-13 | The Research Foundation For The State University Of New York | Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction |
| SG11202001162TA (en) | 2017-09-07 | 2020-03-30 | Fog Pharmaceuticals Inc | Agents modulating beta-catenin functions and methods thereof |
| WO2019118893A1 (en) | 2017-12-15 | 2019-06-20 | Dana-Farber Cancer Institute, Inc. | Stabilized peptide-mediated targeted protein degradation |
| EP3749678A1 (en) | 2018-02-07 | 2020-12-16 | Dana Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| US11091522B2 (en) | 2018-07-23 | 2021-08-17 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CA3193261A1 (en) | 2020-10-14 | 2022-04-21 | Dana-Farber Cancer Institute, Inc. | Chimeric conjugates for degradation of viral and host proteins and methods of use |
| CA3209603A1 (en) * | 2021-01-28 | 2022-08-04 | Institute For Cancer Research D/B/A/ The Research Institute Of Fox Chase Cancer Center | Treatment of integrin-related disorders with stapled peptides |
| IL309067A (en) | 2021-06-09 | 2024-02-01 | Scripps Research Inst | Long-acting dual gip/glp-1 peptide conjugates and methods of use |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811515A (en) * | 1995-06-12 | 1998-09-22 | California Institute Of Technology | Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis |
| WO2000052210A2 (en) | 1999-03-01 | 2000-09-08 | Variagenics, Inc. | Methods for targeting rna molecules |
| US7192713B1 (en) * | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| CA2524258C (en) * | 2003-05-01 | 2012-08-07 | Cornell Research Foundation, Inc. | Carrier complexes comprising cationic peptides for delivering molecules to cells |
| CN103467588B (zh) | 2003-11-05 | 2016-12-28 | 达纳-法伯癌症研究所股份有限公司 | 稳定的α螺旋肽及其用途 |
| EP1786458A2 (en) * | 2004-03-17 | 2007-05-23 | 7TM Pharma A/S | Y2/y4 selective receptor agonists for therapeutic interventions |
| WO2005090388A1 (en) * | 2004-03-19 | 2005-09-29 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
| WO2005118620A2 (en) * | 2004-05-27 | 2005-12-15 | New York University | Methods for preparing internally constraied peptides and peptidomimetics |
| US7084248B2 (en) | 2004-07-14 | 2006-08-01 | Gene Tools, Llc | Peptide composition and method for delivering substances into the cytosol of cells |
| WO2006103666A2 (en) | 2005-03-28 | 2006-10-05 | Yeda Research And Development Co. Ltd. | Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| EP2091552A4 (en) * | 2006-11-15 | 2010-01-06 | Dana Farber Cancer Inst Inc | STABILIZED MAML-PEPTIDES AND ITS USES |
| EP3170835A1 (en) | 2006-12-14 | 2017-05-24 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| US7981998B2 (en) * | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| US8889632B2 (en) | 2007-01-31 | 2014-11-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| EP2564862B1 (en) * | 2007-02-23 | 2017-08-02 | Aileron Therapeutics, Inc. | Substituted amino acids for preparing triazole linked macrocyclic peptides |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| JP5883220B2 (ja) | 2007-05-02 | 2016-03-09 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 細胞のホメオスタシス経路および細胞の生存を調節する方法 |
| WO2009110952A2 (en) | 2007-12-31 | 2009-09-11 | New York University | Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| WO2009108261A2 (en) | 2008-01-23 | 2009-09-03 | Dana Farber Cancer Institute | Compositions and methods for the treatment of viral infections |
| CN104474529A (zh) | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
| US20110144303A1 (en) | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
| WO2009126292A2 (en) | 2008-04-08 | 2009-10-15 | Aileron Therapeutics, Inc. | Biologically active peptidomimetic macrocycles |
| EP2285970A4 (en) | 2008-06-03 | 2011-10-12 | Aileron Therapeutics Inc | COMPOSITIONS AND METHODS FOR REINFORCING THE CELL TRANSPORT OF BIOMOLECULES |
| WO2010011313A2 (en) | 2008-07-23 | 2010-01-28 | President And Fellows Of Harvard College | Ligation of stapled polypeptides |
| JP2012503013A (ja) | 2008-09-18 | 2012-02-02 | ニューヨーク ユニバーシティ | ＨＩＦ−１αと水素結合代替ヘリックスを有するｐ３００／ＣＢＰの間の相互作用の阻害 |
| BRPI0920889A2 (pt) | 2008-09-22 | 2017-10-10 | Aileron Therapeutics Inc | macrociclos peptidomiméticos. |
| CN102482336B (zh) | 2008-09-22 | 2015-05-06 | 爱勒让治疗公司 | 拟肽大环化合物 |
| CA2737918A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2010034032A2 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutic, Inc. | Methods for preparing purified polypeptide compositions |
| CA2737914A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| EP2342214A1 (en) | 2008-09-22 | 2011-07-13 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| JP2012509902A (ja) * | 2008-11-24 | 2012-04-26 | エルロン・セラピューティクス・インコーポレイテッド | 改善された特性を有するペプチド模倣大環状分子 |
| WO2010083347A2 (en) | 2009-01-14 | 2010-07-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2011008260A2 (en) | 2009-07-13 | 2011-01-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| CA2774973A1 (en) | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CA2777700A1 (en) | 2009-10-14 | 2011-04-21 | Aileron Therapeutics, Inc. | Improved peptidomimetic macrocycles |
| RU2016111360A (ru) | 2010-08-13 | 2018-11-27 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
| CA2828889A1 (en) | 2011-03-04 | 2012-09-13 | New York University | Hydrogen bond surrogate macrocycles as modulators of ras |
| WO2012173846A2 (en) | 2011-06-06 | 2012-12-20 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2013033645A1 (en) | 2011-08-31 | 2013-03-07 | New York University | Thioether-,ether-, and alkylamine-linked hydrogen bond surrogate pertidomimentics |
| WO2013059530A2 (en) | 2011-10-18 | 2013-04-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| RU2017145921A (ru) | 2012-02-15 | 2019-02-21 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
| CN104812384B (zh) | 2012-11-01 | 2020-09-18 | 爱勒让治疗公司 | 二取代的氨基酸及其制备和使用方法 |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
-
2009
- 2009-09-22 CN CN200980142223.9A patent/CN102482336B/zh not_active Expired - Fee Related
- 2009-09-22 BR BRPI0918948A patent/BRPI0918948A2/pt not_active Application Discontinuation
- 2009-09-22 JP JP2011528084A patent/JP5711128B2/ja not_active Expired - Fee Related
- 2009-09-22 CA CA2737922A patent/CA2737922A1/en not_active Abandoned
- 2009-09-22 ES ES09736335.2T patent/ES2666458T3/es active Active
- 2009-09-22 WO PCT/US2009/057934 patent/WO2010034034A1/en not_active Ceased
- 2009-09-22 EP EP09736335.2A patent/EP2342222B1/en not_active Not-in-force
- 2009-09-22 US US12/564,910 patent/US8524653B2/en not_active Expired - Fee Related
- 2009-09-22 AU AU2009294877A patent/AU2009294877C1/en not_active Ceased
-
2011
- 2011-03-21 IL IL211836A patent/IL211836A0/en active IP Right Grant
-
2012
- 2012-02-03 US US13/366,113 patent/US8399405B2/en not_active Expired - Fee Related
-
2013
- 2013-08-02 US US13/957,667 patent/US9175045B2/en not_active Expired - Fee Related
-
2014
- 2014-07-11 JP JP2014142904A patent/JP6067626B2/ja not_active Expired - Fee Related
-
2015
- 2015-09-25 US US14/866,445 patent/US20160096873A1/en not_active Abandoned
-
2016
- 2016-08-16 JP JP2016159624A patent/JP2016190882A/ja active Pending
- 2016-09-06 US US15/257,807 patent/US20170299576A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014221801A5 (enExample) | ||
| JP2012503026A5 (enExample) | ||
| JP2022046510A (ja) | 血清アルブミン結合フィブロネクチンｉｉｉ型ドメイン | |
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| CY1121049T1 (el) | Καινοτομες αλληλουχιες σηματος για τη βελτιωση των πρωτεϊνικων εκφρασεων και της εκκρισης των ανασυνδυασμενων ενζυμων και αλλων πρωτεϊνων | |
| RU2010151725A (ru) | Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их | |
| JP2015530404A5 (enExample) | ||
| JP2018527912A5 (enExample) | ||
| JP2020521117A5 (enExample) | ||
| JP2013541335A5 (enExample) | ||
| JP2016516735A5 (enExample) | ||
| JP2019519215A5 (enExample) | ||
| JP2015516813A5 (enExample) | ||
| KR100930973B1 (ko) | 옥시테트라사이클린에 특이적으로 결합하는 ｄｎａ 앱타머및 그 제조방법 | |
| JP2014526881A5 (enExample) | ||
| JP2012512389A5 (enExample) | ||
| CY1117283T1 (el) | Σταθερα μονομερη και ολιγομερη αμυλοειδους βητα | |
| RU2017114396A (ru) | Способ измерения реактивности fviii | |
| Fried et al. | Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein‐1 variants expressed by placental malaria parasites | |
| ATE547523T1 (de) | Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden | |
| JP2013504751A5 (enExample) | ||
| CN105968205A (zh) | 一种抗前列腺特异性膜抗原的纳米抗体 | |
| BRPI0517362A (pt) | polipeptìdeo, molécula de ácido nucleico purificada, vetor, célula hospedeira, anticorpo, métodos in vitro para diagnosticar uma doença em um paciente, composição farmacêutica, composição de vacina, uso de um polipeptìdeo, proteina de fusão, e, método para produção de proteìna | |
| CN108864282A (zh) | 一种鸭tlr2胞外区多克隆抗体及其制备方法与应用 | |
| JP2017525368A5 (enExample) |